4.8 Article

Histone arginine methylation keeps RUNX1 target genes in an intermediate state

期刊

ONCOGENE
卷 32, 期 20, 页码 2565-2575

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/onc.2012.274

关键词

epigenetics; stem cell; histone modifications; poised state; RUNX1

资金

  1. LOEWE initiatives Onkogene Signaltransduktion Frankfurt (OSF)
  2. LOEWE Center for Cell and Gene Therapy Frankfurt (CGT), Ministry of Higher Education, Research and the Arts of the state of Hessen (HMWK) [III L 4-518/55.004, III L 4-518/17004]
  3. institutional funds of the Georg-Speyer-Haus
  4. German Federal Ministry of Health (BMG)
  5. HMWK
  6. Deutsche Forschungsgemeinschaft [SPP-1463, LA 1389/5-1]

向作者/读者索取更多资源

The coordinated recruitment of epigenetic regulators of gene expression by transcription factors such as RUNX1 (AML1, acute myeloid leukemia 1) is crucial for hematopoietic differentiation. Here, we identify protein arginine methyltransferase 6 (PRMT6) as a central functional component of a RUNX1 corepressor complex containing Sin3a and HDAC1 in human hematopoietic progenitor cells. PRMT6 is recruited by RUNX1 and mediates asymmetric histone H3 arginine-2 dimethylation (H3R2me2a) at megakaryocytic genes in progenitor cells. H3R2me2a keeps RUNX1 target genes in an intermediate state with concomitant H3K27me3 and H3K4me2 but not H3K4me3. Upon megakaryocytic differentiation PRMT6 binding is lost, the H3R2me2a mark decreases and a coactivator complex containing WDR5/MLL and p300/pCAF is recruited. This leads to an increase of H3K4me3 and H3K9ac, which result in augmented gene expression. Our results provide novel mechanistic insight into how RUNX1 activity in hematopoietic progenitor cells maintains differentiation genes in a suppressed state but poised for rapid transcriptional activation.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据